SYRE Stock-Based Compensation
Spyre Therapeutics Inc · Stock-Based Compensation
SYRE Stock-Based Compensation
Latest reported$45.70Mperiod ending
SYRE Stock-Based Comp ($147.00K → $45.70M)
Annual stock-based compensation
High-resolution chart · PNG
SYRE stock-based compensation history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 37,614,000 | |
| 44,833,000 | |
| 25,675,000 | |
| 7,111,000 | |
| 8,038,000 | |
| 6,256,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 767,000 | |
| 147,000 |